Tüdőrák: vizsgálatok itt: Izrael
68 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Beer Ya'akov, Haifa, Jerusalem, Kefar Sava, Petah Tikva, Ramat Gan, Tel Aviv
- Életkor
- 18 év and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - No phaseTaking peopleEx Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 400
- Run by
- Sheba Medical Center
See details and how to joinNCT07636252 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 10
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT05632913 - 1. fázisTaking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Jerusalem, Petah Tikva, Ramat Gan
- Életkor
- 18 év and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - 1. fázisTaking peoplePhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
- Where
- Kfar Saba, Tel HaShomer
- Életkor
- 18 év and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00 - No phaseTaking peopleAssociation Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
- Where
- Tel Aviv
- Életkor
- 18 év and over
- People
- 300
- Run by
- Daniel Keizman
See details and how to joinNCT07485114 - 1/2. fázisTaking peopleAutologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 50
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00722228 - 1/2. fázisTaking peopleAnti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Where
- Jerusalem
- Életkor
- 18 év to 70 év
- People
- 3
- Run by
- Hadassah Medical Organization
See details and how to joinNCT05296564 - No phaseTaking peopleReal World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 60
- Run by
- Sheba Medical Center
See details and how to joinNCT07131163 - 2. fázisNot yet taking people in IzraelTracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer
- Where
- Petah Tikva
- Életkor
- 18 év and over
- People
- 30
- Run by
- Rabin Medical Center
See details and how to joinNCT06951399 - No phaseTaking peopleNovel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 300
- Run by
- JaxBio Ltd
See details and how to joinNCT06963307 - No phaseCsak meghívásosALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study
- Where
- Ramat Gan
- Életkor
- 18 év and over
- People
- 200
- Run by
- Sheba Medical Center
See details and how to joinNCT06846736 - 2. fázisTaking peopleFirst Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy
- Where
- Jerusalem
- Életkor
- 18 év to 99 év
- People
- 21
- Run by
- Nir Peled
See details and how to joinNCT06667167 - No phaseTaking peopleFirst in Human Study for the Assessment of Safety and Initial Performance of the EAS1 System
- Where
- Kfar Saba
- Életkor
- 18 év to 80 év
- People
- 15 worldwide
- Run by
- Snipe Medical
See details and how to joinNCT06423690 - 2. fázisTaking peopleFecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
- Where
- Beersheba, Petah Tikva
- Életkor
- 18 év and over
- People
- 80
- Run by
- Soroka University Medical Center
See details and how to joinNCT05502913 - No phaseNot yet taking people in IzraelA Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 50
- Run by
- Nir Peled
See details and how to joinNCT05698264 - No phaseTaking peopleI3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 2200 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT05537922 - No phaseTaking peopleA Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
- Where
- Jerusalem
- Életkor
- 18 év to 120 év
- People
- 162
- Run by
- Hadassah Medical Organization
See details and how to joinNCT05033691